Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up
Stock Investor Wire

BPMC Quote, Trading Chart, Blueprint Medicines Corporation


home / stock / bpmc / bpmc quote

$98.22 Last:

2.22% Change Percent:

$96.9 Open:

$98.22 Previous Close:

$99.17 High:

$94.03 Low:

454,432 Volume:

02/26/2021 04:55:21 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Last Five Trading Days

Stock DateOpen PriceClose PriceHighLowVolume
2021-02-2696.998.2299.1794.03454,432
2021-02-2597.7496.0998.710594.83341,402
2021-02-2497.1797.7998.9694.95303,002
2021-02-2396.3597.4599.9294.04441,602
2021-02-2299.7597.9610096.85351,193
2021-02-1996.81100.31101.5296.61481,598
2021-02-1899.496.7499.496338,822
2021-02-1790.47100.25102.6790.41786,210
2021-02-1697.0693.297.881593.05423,897
2021-02-15100.4596.97100.696.225287,512
2021-02-12100.4596.97100.696.225285,618
2021-02-11100.58100.31102.039998.18397,131
2021-02-10103.0199.38103.74598.23424,684
2021-02-09105.28103.19106.94102.89295,302
2021-02-08103105.45107.1101.0601484,146
2021-02-0599.59102102.4998.695335,764
2021-02-0496.1598.9798.9895.49215,543
2021-02-03100.1996.35100.395.55399,750
2021-02-02100.29100.35103.2499.59467,707
2021-02-0197.5498.5798.895529,815
Stock Information

Blueprint Medicines Corporation Company Name:

BPMC Stock Symbol:

NASDAQ Market:

Blueprint Medicines Corporation Website:

BPMC Quote, Trading Chart, Blueprint Medicines Corporation

MENU
BPMC BPMC Quote BPMC Short BPMC News BPMC Articles BPMC Message Board
Get BPMC Alerts

News, Short Squeeze, Breakout and More Instantly...

Stock Investor Wire
RECENT BPMC NEWS
  • BPMC - Blueprint Medicines Reports Fourth Quarter and Full Year 2020 Financial Results

    Blueprint Medicines Reports Fourth Quarter and Full Year 2020 Financial Results -- Supplemental NDA accepted by FDA for AYVAKIT™ (avapritinib) for advanced systemic mastocytosis -- -- Type II variation MAA submitted to EMA for AYVAKYT® (avapritinib) for advanced ...

  • BPMC - Blueprint Medicines to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 17, 2021

    Blueprint Medicines to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 17, 2021 PR Newswire CAMBRIDGE, Mass. , Feb. 10, 2021 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused...

  • BPMC - Blueprint Medicines Announces R&D Leadership Transitions

    Blueprint Medicines Announces R&D Leadership Transitions Blueprint Medicines Announces R&D Leadership Transitions -- Becker Hewes, M.D., promoted to Chief Medical Officer -- -- Andy Boral, M.D., Ph.D., to transition from Chief Medical Officer to Executive Vice Pr...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your Twitter Account

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.


Sign up or login to continue

Sign up or login to continue.


Forgot password?




WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Member Benefits

Member Coins


Log In

Sign Up

Stay Connected
Follow @marketWN

Contact

Privacy

Terms of Service

Disclaimer

© 2020 Market Wire News